Profile data is unavailable for this security.
About the company
EvoNext Holdings Ltd, previously Evolva Holding Ltd, is a Switzerland-based Company operating as a researcher for biotechnology. The Company develops and commercializes nature-based ingredients. The ingredients, produced by the Company, can be employed in, but not limited to, flavorings fragrancies, health ingredients, health protection and other various sectors. The objectives of the Company are as follows: develop technology platforms - combines biology with technology to produce nature-based ingredients; provide technology services- provides tailored services to clients across industries. The Company is focused on developing and increasing the return and effectiveness of the production of numerous ingredients within their portfolio.
- Revenue in CHF (TTM)0.00
- Net income in CHF-850.90k
- Incorporated1997
- Employees0.00
- LocationEvoNext Holdings LtdDuggingerstrasse 23REINACH 4153SwitzerlandCHE
- Phone+41 614852000
- Fax+41 614852001
- Websitehttps://evonextholdings.com/
More ▼
Mergers & acquisitions
| Acquired company | EVE:SWX since announced | Transaction value |
|---|---|---|
| Gzo AG Spital Wetzikon | -9.35% | -- |
Data delayed at least 15 minutes, as of Feb 16 2026 16:31 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Genomics SA | 0.00 | -8.10m | 4.58m | 2.00 | -- | -- | -- | -- | -0.1276 | -0.1276 | 0.00 | -0.0352 | 0.00 | -- | -- | 0.00 | -433.64 | -70.24 | -858.41 | -123.45 | -- | -3,200.37 | -- | -3,364.53 | -- | -131.86 | 14.44 | -- | -100.00 | -- | -180.44 | -- | -- | -- |
| TheraCryf PLC | 0.00 | -2.11m | 4.73m | 9.00 | -- | 0.9398 | -- | -- | -0.0017 | -0.0017 | 0.00 | 0.0022 | 0.00 | -- | -- | 0.00 | -41.20 | -38.70 | -53.79 | -42.97 | -- | -- | -- | -1,407.46 | -- | -- | 0.00 | -- | -100.00 | -- | 38.13 | -- | -- | -- |
| Acousort AB | 483.08k | -1.06m | 4.77m | 16.00 | -- | 2.97 | -- | 9.88 | -0.7188 | -0.7188 | 0.3101 | 0.8814 | 0.2799 | -0.0274 | 49.25 | 350,937.50 | -61.61 | -48.79 | -81.29 | -71.44 | 101.21 | 63.17 | -220.12 | -285.72 | 4.51 | -- | 0.00 | -- | -14.40 | 20.61 | 11.77 | -- | -- | -- |
| Cizzle Biotechnology Holdings PLC | 0.00 | -1.18m | 5.61m | 67.00 | -- | -- | -- | -- | -0.0028 | -0.0028 | 0.00 | -0.0007 | 0.00 | -- | -- | -- | -190.34 | -146.14 | -433.59 | -169.40 | -- | -- | -- | -- | 0.4766 | -2.42 | -- | -- | -- | -- | -26.15 | -- | -- | -- |
| Chosa Oncology AB | 61.69k | -516.72k | 5.63m | -- | -- | 4.06 | -- | 91.33 | -0.0766 | -0.0766 | 0.0096 | 0.2044 | 0.0382 | -- | 0.8639 | -- | -32.00 | -55.65 | -35.30 | -67.69 | 643.24 | -- | -837.66 | -792.50 | -- | -49.05 | 0.00 | -- | -39.73 | -62.56 | 59.93 | -- | -- | -- |
| EvoNext Holdings Ltd | 0.00 | -850.90k | 6.15m | 0.00 | -- | 0.9831 | -- | -- | -0.1188 | -0.1188 | 0.00 | 0.8646 | 0.00 | -- | -- | -- | -11.30 | -38.79 | -12.77 | -43.27 | -- | -38.22 | -- | -515.82 | -- | -- | 0.00 | -- | -100.00 | -- | 100.99 | -- | -- | -- |
| Lifecare ASA | 147.41k | -10.00m | 6.21m | 28.00 | -- | -- | -- | 42.11 | -2.48 | -2.48 | 0.0379 | -0.11 | 0.0168 | -- | 0.1582 | 55,272.73 | -115.30 | -52.64 | -194.19 | -61.98 | -- | -- | -6,864.75 | -277.39 | -- | -- | 1.17 | -- | -26.10 | 36.13 | -103.52 | -- | -- | -- |
| Opsy Holding AB | 355.24k | -1.61m | 6.55m | 7.00 | -- | 49.33 | -- | 18.45 | -20.83 | -20.83 | 0.6321 | 0.1216 | 0.294 | -- | 7.63 | 2,064,500.00 | -133.11 | -117.68 | -201.35 | -142.11 | 154.30 | -- | -452.72 | -- | -- | -216.84 | 0.463 | -- | -- | -- | -43.22 | -- | -- | -- |
| OptiBiotix Health PLC | 1.21m | -200.13k | 6.82m | 5.00 | -- | 0.7729 | 464.85 | 5.65 | -0.0018 | -0.0018 | 0.0113 | 0.0815 | 0.134 | 1.93 | 2.88 | 230,200.00 | -2.22 | 17.23 | -2.33 | 17.84 | 45.44 | 50.78 | -16.59 | 189.34 | 3.75 | -- | 0.00 | 94.93 | 35.09 | 3.15 | 11.48 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 37.60k | -2.28m | 6.83m | 7.00 | -- | 2.58 | -- | 181.67 | -0.0513 | -0.0513 | 0.0008 | 0.0465 | 0.0115 | -- | 4.39 | 62,428.57 | -69.64 | -30.44 | -81.41 | -32.48 | -- | -- | -6,076.43 | -3,410.33 | -- | -- | -- | -- | -77.13 | 5.02 | 18.32 | -- | -- | -- |
| IDL Diagnostics AB (publ) | 4.49m | -3.38m | 7.31m | 22.00 | -- | 0.5681 | -- | 1.63 | -0.1706 | -0.1706 | 0.2266 | 0.6495 | 0.3263 | 6.59 | 5.26 | 2,372,364.00 | -24.58 | -29.04 | -26.98 | -31.14 | 21.53 | 1.70 | -75.32 | -157.60 | 3.29 | -- | 0.0843 | -- | 33.45 | 164.62 | 28.41 | -- | 18.85 | -- |
| Medicofarma Biotech SA | 60.89k | -660.99k | 7.35m | 24.00 | -- | 7.14 | -- | 120.76 | -0.0450 | -0.0450 | 0.0041 | 0.07 | 0.0199 | 66.64 | 0.7469 | 11,727.08 | -21.55 | -14.96 | -31.48 | -18.59 | 38.80 | 36.02 | -1,085.51 | -64.02 | 0.821 | -11.71 | 0.00 | -- | 63.14 | -17.39 | 33.11 | -- | -- | -- |
| 1nkemia IUCT Group SA | 4.98m | -22.15m | 7.62m | 45.00 | -- | -- | -- | 1.53 | -0.9012 | -0.9012 | 0.2024 | -0.2897 | 0.202 | 1.31 | 2.14 | -- | -90.11 | -56.59 | -171.35 | -7,853.16 | 91.46 | 109.22 | -445.97 | -319.63 | 0.264 | 3.18 | 1.74 | -- | -71.31 | -60.97 | -346.13 | -- | -78.18 | -- |
| Futura Medical PLC | 8.31m | -6.60m | 7.89m | 12.00 | -- | 1.29 | -- | 0.9497 | -0.0207 | -0.0207 | 0.0261 | 0.01 | 1.06 | 137.36 | 8.58 | -- | -84.19 | -45.00 | -112.42 | -71.79 | 70.67 | -- | -79.41 | -108.25 | 2.21 | -- | 0.00 | -- | 349.09 | 237.55 | 119.85 | -- | 121.02 | -- |
| Talisman Metals PLC | 0.00 | 68.33k | 8.05m | 1.00 | -- | 3.21 | 117.83 | -- | -0.0064 | -0.016 | 0.00 | 0.0373 | 0.00 | -- | -- | 0.00 | 3.15 | -30.40 | 3.64 | -33.15 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 99.94 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to EvoNext Holdings Ltd's reporting currency: Swiss Franc CHF
2.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Asset Management Switzerland AGas of 03 Feb 2026 | 99.95k | 1.38% |
| amandea Verm�gensverwaltung AGas of 30 Sep 2025 | 67.87k | 0.94% |
| Z�rcher Kantonalbank (Investment Management)as of 31 Dec 2025 | 29.95k | 0.41% |
| BlackRock Asset Management Deutschland AGas of 05 Feb 2026 | 9.67k | 0.13% |
| Swiss Life Asset Management AGas of 30 Sep 2025 | 1.29k | 0.02% |
| Quorus Verm�gensverwaltung AGas of 31 Dec 2025 | 800.00 | 0.01% |
| BlackRock Advisors (UK) Ltd.as of 31 Jul 2025 | 720.00 | 0.01% |
| Carne Global Fund Managers (Schweiz) AGas of 31 Dec 2025 | 476.00 | 0.01% |
| LLB Asset Management AGas of 31 Dec 2025 | 240.00 | 0.00% |
| Dux Inversores SGIIC SAas of 31 Dec 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
